DARATUMUMAB, A CD38 MONOCLONAL ANTIBODY STUDY IN ADVANCED MULTIPLE MYELOMA - AN OPEN-LABEL, DOSE ESCALATION FOLLOWED BY OPEN-LABEL EXTENSION IN A SINGLE-ARM PHASE I/II STUDY

被引：0
|
作者：
Lokhorst, H. [1 ]
Plesner, T. [2 ]
Gimsing, P. [3 ]
Nahi, H. [4 ]
Lisby, S. [5 ]
Richardson, P. [6 ]
机构：
[1] Univ Med Ctr Utrecht, Utrecht, Netherlands
[2] Vejie Hosp, Vejie, Denmark
[3] Copenhagen Univ Hosp, Copenhagen, Denmark
[4] Karolinska Univ Hosp, Stockholm, Sweden
[5] Genmab A S, Copenhagen, Denmark
[6] Dana Farber Canc Inst, Boston, MA 02115 USA
来源：
HAEMATOLOGICA | 2013年 / 98卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
S576
引用
收藏
页码：241 / 241
页数：1
相关论文
共 50 条
  • [41] Camrelizumab in combination with preoperative chemotherapy for locally advanced esophageal squamous cell carcinoma: A single-arm, open-label, phase II study
    Wang Feng
    Qi Yu
    Meng Xiangrui
    Fan Qingxia
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (03)
  • [42] Single-arm, open-label, dose-escalation phase I study to evaluate the safety of a herbal medicine SH003 in patients with solid cancer: a study protocol
    Cheon, Chunhoo
    Kang, Sohyeon
    Ko, Youme
    Kim, Mia
    Jang, Bo-Hyoung
    Shin, Yong-Cheol
    Ko, Seong-Gyu
    BMJ OPEN, 2018, 8 (08):
  • [43] Phase I/II, Multicenter, Open-Label, Dose-Escalation Study of Bendamustine in Combination with Lenalidomide and Dexamethasone (BRD) in Patients with Relapsed Multiple Myeloma: A Multiple Myeloma Research Consortium Study
    Kumar, Shaji K.
    Krishnan, Amrita
    Roy, Vivek
    Zimmerman, Todd M.
    Gertz, Morie Abraham A.
    Stockerl-Goldstein, Keith E.
    Buadi, Francis K.
    Rosenbaum, Cara
    Birgin, Ann
    Fiala, Mark
    Jiminez, Valeria
    Maharaj, Michele
    Needle, Michael N.
    Vij, Ravi
    BLOOD, 2012, 120 (21)
  • [44] Efficacy and safety of nivolumab in combination with ipilimumab in Japanese patients with advanced melanoma: An open-label, single-arm, multicentre phase II study
    Namikawa, Kenjiro
    Kiyohara, Yoshio
    Takenouchi, Tatsuya
    Uhara, Hisashi
    Uchi, Hiroshi
    Yoshikawa, Shusuke
    Takatsuka, Sumiko
    Koga, Hiroshi
    Wada, Naoko
    Minami, Hironobu
    Hatsumichi, Masahiro
    Asada, Suguru
    Namba, Yoshinobu
    Yamazaki, Naoya
    EUROPEAN JOURNAL OF CANCER, 2018, 105 : 114 - 126
  • [45] Efficacy and safety of sorafenib in combination with gemcitabine in patients with advanced hepatocellular carcinoma: A multicenter, open-label, single-arm phase II study
    Srimuninnimit, Vichien
    Sriuranpong, Virote
    Suwanvecho, Suthida
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2014, 10 (03) : 255 - 260
  • [46] An open-label, single-arm, phase 2 study of the Aurora kinase A inhibitor alisertib in patients with advanced urothelial cancer
    Andrea Necchi
    Salvatore Lo Vullo
    Luigi Mariani
    Daniele Raggi
    Patrizia Giannatempo
    Giuseppina Calareso
    Elena Togliardi
    Flavio Crippa
    Nicola Di Genova
    Federica Perrone
    Maurizio Colecchia
    Biagio Paolini
    Giuseppe Pelosi
    Nicola Nicolai
    Giuseppe Procopio
    Roberto Salvioni
    Filippo G. De Braud
    Investigational New Drugs, 2016, 34 : 236 - 242
  • [47] An open-label, single-arm, phase 2 study of the Aurora kinase A inhibitor alisertib in patients with advanced urothelial cancer
    Necchi, Andrea
    Lo Vullo, Salvatore
    Mariani, Luigi
    Raggi, Daniele
    Giannatempo, Patrizia
    Calareso, Giuseppina
    Togliardi, Elena
    Crippa, Flavio
    Di Genova, Nicola
    Perrone, Federica
    Colecchia, Maurizio
    Paolini, Biagio
    Pelosi, Giuseppe
    Nicolai, Nicola
    Procopio, Giuseppe
    Salvioni, Roberto
    De Braud, Filippo G.
    INVESTIGATIONAL NEW DRUGS, 2016, 34 (02) : 236 - 242
  • [48] CF102 FOR THE TREATMENT OF HEPATOCELLULAR CARCINOMA: A PHASE I/II, OPEN-LABEL, DOSE-ESCALATION STUDY
    Stemmer, S. M.
    Benjaminov, O.
    Medalia, G.
    Ciuraru, N. B.
    Silverman, M. H.
    Bar-Yehuda, S.
    Fishman, S.
    Harpaz, Z.
    Farbstein, M.
    Cohen, S.
    Patoka, R.
    Singer, B.
    Kerns, W. D.
    Fishman, P.
    JOURNAL OF HEPATOLOGY, 2012, 56 : S555 - S555
  • [49] PRELIMINARY RESULTS OF THE OPERA I AND OPERA II OPEN-LABEL EXTENSION STUDY
    Naismith, Robert
    Cascione, Mark
    Grimaldi, Luigi
    Hauser, Stephen
    Kappos, Ludwig
    Montalban, Xavier
    Wolinsky, Jerry
    Chin, Peter
    Garren, Hideki
    Julian, Laura
    Model, Fabian
    Honeycutt, David
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2017, 88 (05):
  • [50] SUBCUTANEOUS DARATUMUMAB IN PATIENTS (PTS) WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA (RRMM): AN OPEN-LABEL, MULTICENTER, DOSE ESCALATION PHASE 1B STUDY (PAVO)
    Mateos, M., V
    Chari, A.
    Nah, H.
    Lokhorst, H.
    Kaufman, J. L.
    Moreau, P.
    Oriol, A.
    Plesner, T.
    Benboubker, L.
    Hellemans, P.
    Masterson, T.
    Clemens, P. L.
    Liu, K.
    San-Miguel, J.
    Usmani, S. Z.
    HAEMATOLOGICA, 2018, 103 : 32 - 33
12345